To learn more about our prospective biomarker study please click here.
Idylla™ MSI Available Now! Click here for more information
BACK TO EVENTS

Tuesday, March 19, 2019 | Gaylord Convention Center

USCAP

The 2019 program is designed to exceed your expectations and expose you to contemporary and vibrant pathology education at its best. The Academy encourages you to make the most of this conference, designed for a broad spectrum of learning and social opportunities from the Long Course on Dermatopathology to the extraordinary Celebrate In-GEN-U-ity Party.

TIME & LOCATION

Tuesday, March 19, 2019

Gaylord Convention Center
Maryland


VISIT US AT USCAP 2019 IN BALTIMORE!
Come and see us at Booth #615 and learn more about our Idylla™ solution at the Biocartis seminar on Tuesday, March 19!
POTENTIAL OF ULTRA-RAPID MUTATIONAL ANALYSIS IN ONCOLOGY BASED APPLICATIONS

Ultra-rapid mutational analysis complementing NGS workflows in high volume laboratories
Maria E. Arcila, MD, Director, Diagnostic Molecular Pathology Laboratory
Memorial Sloan Kettering Cancer Center, New York, NY

Somatic mutation analysis: Beyond the FFPE tissue section
Gregory J. Tsongalis, PhD, Director, Laboratory for Clinical Genomics and
Advanced Technology, Dartmouth-Hitchcock Medical Center, Lebanon, NH

Fully automated biomarker analysis on samples challenging for traditional molecular methods
Stacey S. O’Neill, MD, Assistant Professor of Pathology,
Wake Forest Baptist Health, Winston-Salem, NC

Request A Demo

Biocartis is recruiting centers for a prospective biomarker study comparing turnaround times of standard of care methods and biomarker testing with Idylla™.

One of the biggest challenges oncology labs face with biomarker testing is the ability to obtain samples of sufficient size and quality. With the Idylla™ system only a minimal amount of sample is needed. For solid biopsies, just one slice of tissue is enough and our plasma-based assays require only 1 ml of plasma.